![John Smither](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Smither
Directeur Financier/CFO chez
MBX BIOSCIENCES, INC.
Fortune : 306 869 $ au 31/05/2026
Profil
Mr. John W.
Smither, CPA, is a Chief Financial Officer at MBX Biosciences, Inc., an Independent Director at Genelux Corp., an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV, a Member at California Society of Certified Public Accountants, a Member at Financial Executives International and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Genelux Corp., NewAmsterdam Pharma Co. NV and eFFECTOR Therapeutics Operations, Inc. Mr. Smither was previously employed as a Chief Financial Officer by Arcutis Biotherapeutics, Inc., an Independent Director by Applied Molecular Transport, Inc., a Chief Financial Officer by Arcutis Biotherapeutics, Inc., an Independent Director by Principia Biopharma, Inc., a Chief Financial Officer by Sienna Biopharmaceuticals, Inc., an Independent Director by eFFECTOR Therapeutics, Inc., a Chief Financial Officer by Kite Pharma, Inc., a Chief Financial Officer by Sienna Biopharmaceuticals, Inc., a Chief Financial Officer by Unity Biotechnology, Inc., an Independent Director by Achaogen, Inc., a Chief Financial Officer by Kythera Biopharmaceuticals Inc, a Chief Financial Officer by Amgen Europe BV, a Vice President-Finance & Administration by Amgen, Inc., and an Audit Partner by Ernst & Young LLP (Missouri).
He also served on the board at Dompe Biotec SpA. He received his undergraduate degree from California State University-Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENELUX CORP. 0,17 % | 16/03/2026 | 74 994 ( 0,17 % ) | 228 732 $ | 31/05/2026 |
| 15/04/2026 | 2 320 ( 0 % ) | 78 138 $ | 31/05/2026 |
Postes actifs de John Smither
| Sociétés | Poste | Début |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Directeur/Membre du Conseil | 01/01/2023 |
| GENELUX CORPORATION | Directeur/Membre du Conseil | 11/09/2023 |
| MBX BIOSCIENCES, INC. | Directeur Financier/CFO | 16/05/2026 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Directeur/Membre du Conseil | 23/03/2018 |
Financial Executives International
 Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates association for treasurers, controllers, tax executives, and others in financial services | Corporate Officer/Principal | - |
California Society of Certified Public Accountants | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Anciens postes connus de John Smither
| Sociétés | Poste | Fin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 10/04/2024 |
| APPLIED MOLECULAR TRANSPORT INC. | Directeur/Membre du Conseil | 27/12/2023 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de John Smither
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
California State University-Los Angeles
 California State University-Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International
Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates association for treasurers, controllers, tax executives, and others in financial services | Commercial Services |
California Society of Certified Public Accountants | Commercial Services |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Manufactures biotechnological drugs | Health Technology |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
